Drug Profile
Research programme: HIV-1 therapy - Yamasa
Alternative Names: 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine; E2FdA; HIV-1 therapy research programme - YamasaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Yamasa Corporation
- Class Purine nucleosides; Ribonucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections